Jury Finds Pharma Exec 'Shadow Traded' With Inside Info

A California federal jury found Friday that a former Medivation executive is liable for using inside information from his company when he purchased stock in rival pharmaceutical maker Incyte, in a...

Already a subscriber? Click here to view full article